Important RCT on Trigger Finger: Splinting, Not Shots, Should be First-line Treatment

Results of this don't-miss randomized trial are practical — and should be practice-changing

Smart Practice: Splinting should be the initial treatment for adults with trigger finger.

What’s the Claim?

A randomized trial comparing splinting alone, corticosteroid injection, or splinting + steroid injection for adults with trigger finger found no clinically important differences in VAS pain scores or function (Michigan Hand Outcomes scores) out to one year. There were no differences among the groups in terms of severity of triggering at one year, nor did they differ in terms of the proportion of patients who opted for surgery during the year.

How’s It Stack Up?